Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 14(1): 7726, 2023 Nov 25.
Article in English | MEDLINE | ID: mdl-38001069

ABSTRACT

Clinical immunity against Plasmodium falciparum infection develops in residents of malaria endemic regions, manifesting in reduced clinical symptoms during infection and in protection against severe disease but the mechanisms are not fully understood. Here, we compare the cellular and humoral immune response of clinically immune (0-1 episode over 18 months) and susceptible (at least 3 episodes) during a mild episode of Pf malaria infection in a malaria endemic region of Malawi, by analysing peripheral blood samples using high dimensional mass cytometry (CyTOF), spectral flow cytometry and single-cell transcriptomic analyses. In the clinically immune, we find increased proportions of circulating follicular helper T cells and classical monocytes, while the humoral immune response shows characteristic age-related differences in the protected. Presence of memory CD4+ T cell clones with a strong cytolytic ZEB2+ T helper 1 effector signature, sharing identical T cell receptor clonotypes and recognizing the Pf-derived circumsporozoite protein (CSP) antigen are found in the blood of the Pf-infected participants gaining protection. Moreover, in clinically protected participants, ZEB2+ memory CD4+ T cells express lower level of inhibitory and chemotactic receptors. We thus propose that clonally expanded ZEB2+ CSP-specific cytolytic memory CD4+ Th1 cells may contribute to clinical immunity against the sporozoite and liver-stage Pf malaria.


Subject(s)
Malaria Vaccines , Malaria, Falciparum , Malaria , Humans , Plasmodium falciparum , Malaria, Falciparum/prevention & control , Malaria/prevention & control , Th1 Cells , Protozoan Proteins , Clone Cells
2.
mSystems ; 7(5): e0044222, 2022 10 26.
Article in English | MEDLINE | ID: mdl-36121169

ABSTRACT

Shigella continues to be a major contributor to diarrheal illness and dysentery in children younger than 5 years of age in low- and middle-income countries. Strategies for the prevention of shigellosis have focused on enhancing adaptive immunity. The interaction between Shigella and intrinsic host factors, such as the microbiome, remains unknown. We hypothesized that Shigella infection would impact the developing microbial community in infancy and, conversely, that changes in the gastrointestinal microbiome may predispose infections. To test this hypothesis, we characterized the gastrointestinal microbiota in a longitudinal birth cohort from Malawi that was monitored for Shigella infection using 16S rRNA amplicon sequencing. Children with at least one Shigella quantitative polymerase chain reaction (qPCR) positive sample during the first 2 years of life (cases) were compared to uninfected controls that were matched for sex and age. Overall, the microbial species diversity, as measured by the Shannon diversity index, increased over time, regardless of case status. At early time points, the microbial community was dominated by Bifidobacterium longum and Escherichia/Shigella. A greater abundance of Prevotella 9 and Bifidobacterium kashiwanohense was observed at 2 years of age. While no single species was associated with susceptibility to Shigella infection, significant increases in Lachnospiraceae NK4A136 and Fusicatenibacter saccharivorans were observed following Shigella infection. Both taxa are in the family Lachnospiraceae, which are known short-chain fatty acid producers that may improve gut health. Our findings identified temporal changes in the gastrointestinal microbiota associated with Shigella infection in Malawian children and highlight the need to further elucidate the microbial communities associated with disease susceptibility and resolution. IMPORTANCE Shigella causes more than 180 million cases of diarrhea globally, mostly in children living in poor regions. Infection can lead to severe health impairments that reduce quality of life. There is increasing evidence that disruptions in the gut microbiome early in life can influence susceptibility to illnesses. A delayed or impaired reconstitution of the microbiota following infection can further impact overall health. Aiming to improve our understanding of the interaction between Shigella and the developing infant microbiome, we investigated changes in the gut microbiome of Shigella-infected and uninfected children over the course of their first 2 years of life. We identified species that may be involved in recovery from Shigella infection and in driving the microbiota back to homeostasis. These findings support future studies into the elucidation of the interaction between the microbiota and enteric pathogens in young children and into the identification of potential targets for prevention or treatment.


Subject(s)
Dysentery, Bacillary , Gastrointestinal Microbiome , Shigella , Infant , Humans , Child , Child, Preschool , Gastrointestinal Microbiome/genetics , Dysentery, Bacillary/epidemiology , RNA, Ribosomal, 16S/genetics , Quality of Life , Feces/microbiology , Shigella/genetics , Diarrhea/microbiology
3.
AIDS ; 21(13): 1723-30, 2007 Aug 20.
Article in English | MEDLINE | ID: mdl-17690570

ABSTRACT

OBJECTIVES: This study was conducted to compare viral dynamics in blood and semen between subjects with antibody negative, acute HIV-1 infection and other subjects with later stages of infection. DESIGN: A prospective cohort study was embedded within a cross-sectional study of HIV screening in a Lilongwe, Malawi STD clinic. METHODS: Blood samples from HIV antibody negative or indeterminate volunteers were used to detect HIV RNA in plasma using a pooling strategy. Blood and seminal plasma HIV-1 RNA concentrations were measured over 16 weeks. RESULTS: Sixteen men with acute HIV infection and 25 men with chronic HIV infection were studied. Blood viral load in subjects with acute HIV infection was highest about 17 days after infection (mean +/- SE, 6.9 +/- 0.5 log10 copies/ml), while semen viral load peaked about 30 days after infection (4.5 +/- 0.4 log10 copies/ml). Semen viral load declined by 1.7 log10 to a nadir by week 10 of HIV infection. Semen and blood viral loads were more stable in chronically infected subjects over 16 weeks. Higher semen levels of HIV RNA were noted in subjects with low CD4 cell counts. CONCLUSIONS: These results provide a biological explanation for reported increases in HIV transmission during the very early (acute) and late stages of infection. Recognizing temporal differences in HIV shedding in the genital tract is important in the development of effective HIV prevention strategies.


Subject(s)
HIV Infections/virology , HIV-1/isolation & purification , Semen/virology , Acute Disease , Adolescent , Adult , Chronic Disease , Disease Progression , Epidemiologic Methods , HIV Infections/transmission , Humans , Male , Middle Aged , RNA, Viral/analysis , RNA, Viral/blood , Viral Load , Viremia/virology , Virus Shedding
4.
J Infect Dis ; 195(9): 1278-82, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17396996

ABSTRACT

We measured enteric parasitic infection prevalence and the effect of treatment on human immunodeficiency virus (HIV) RNA levels to assess their importance to HIV primary care in resource-limited settings. Adults in Lilongwe, Malawi, were evaluated, treated, and followed-up for parasitic and HIV infections. Of 389 patients, 266 (68%) were HIV infected. Helminth infections were more common in HIV-uninfected than in HIV-infected patients (39% vs. 17%). Among HIV-infected patients, helminth infections were associated with higher CD4 cell counts but not with higher HIV RNA levels. Successful treatment of parasitic infections had no effect on HIV RNA levels. Although common, parasitic infections did not impact HIV RNA levels.


Subject(s)
HIV Infections/epidemiology , HIV Infections/virology , HIV-1/isolation & purification , Helminthiasis/epidemiology , Intestinal Diseases, Parasitic/epidemiology , Adult , Albendazole/administration & dosage , Albendazole/therapeutic use , Ambulatory Care , Anthelmintics/administration & dosage , Anthelmintics/therapeutic use , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/therapeutic use , CD4 Lymphocyte Count , Feces/parasitology , Female , HIV Infections/blood , HIV Infections/complications , HIV Infections/drug therapy , HIV-1/genetics , Helminthiasis/blood , Helminthiasis/complications , Helminthiasis/drug therapy , Helminthiasis/parasitology , Helminthiasis/urine , Humans , Intestinal Diseases, Parasitic/blood , Intestinal Diseases, Parasitic/complications , Intestinal Diseases, Parasitic/drug therapy , Intestinal Diseases, Parasitic/parasitology , Intestinal Diseases, Parasitic/urine , Malawi/epidemiology , Male , Medically Underserved Area , Metronidazole/administration & dosage , Metronidazole/therapeutic use , Praziquantel/administration & dosage , Praziquantel/therapeutic use , RNA, Viral/analysis , Viral Load , Virus Shedding
5.
J Infect Dis ; 195(3): 416-24, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17205481

ABSTRACT

BACKGROUND: We conducted a prospective study to evaluate methods of detecting clients with sexually transmitted diseases (STDs) who were acutely coinfected with human immunodeficiency virus (HIV) in Lilongwe, Malawi. METHODS: After informed consent was obtained, all clients with acute STDs were offered voluntary HIV counseling and testing by 2 rapid antibody tests. Samples from rapid test-negative or -discordant subjects were pooled (50 : 5 : 1) and tested for HIV RNA. Western blots were performed on all rapid test-discordant specimens with detectable HIV RNA. A subset of specimens received p24 antigen testing with standard and/or ultrasensitive methods. Patients with possible acute HIV infection were followed to confirm seroconversion. RESULTS: A total of 1450 clients (34% female and 66% male) agreed to testing, of whom 588 (40.55%) had established HIV infection and 21 (1.45%) had acute infection. Discordant rapid antibody tests identified 7 of 21 (33.3% sensitivity), standard p24 antigen identified 12 of 16 (75% sensitivity), and ultrasensitive p24 antigen identified 15 of 17 (88% sensitivity) acute cases. By definition, the sensitivity of the RNA assay was 100%. CONCLUSIONS: Real-time pooled RNA testing for the detection of acute HIV infection is feasible in resource-limited settings. However, parallel rapid testing and p24 antigen testing are technologically simpler and together may detect approximately 90% of acute cases.


Subject(s)
HIV Infections/diagnosis , HIV , Acute Disease , Adult , Blotting, Western , Feasibility Studies , Female , HIV/genetics , HIV/isolation & purification , HIV Antibodies/blood , HIV Core Protein p24/blood , HIV Infections/blood , HIV Infections/prevention & control , Humans , Malawi , Male , Prospective Studies , RNA, Viral/blood , Reagent Kits, Diagnostic , Sensitivity and Specificity
6.
J Infect Dis ; 189(10): 1926-31, 2004 May 15.
Article in English | MEDLINE | ID: mdl-15122531

ABSTRACT

Variations in estimates of prevalence of trichomoniasis in men may reflect true differences in the burden of disease but are also affected by the performance of diagnostic methods and the type of specimen tested. In this study, men were evaluated at baseline and at follow-up, to evaluate syndromic management of urethritis and the effects of human immunodeficiency virus and trichomoniasis, in Lilongwe, Malawi. First-void urine specimens and urethral swabs were obtained at enrollment, for Trichomonas vaginalis culture; semen specimens were also obtained at follow-up. The sensitivities of testing methods using urine specimens and urethral swabs were equal; 67% of cases were identified by use of either specimen, and, in 47% of cases, both specimens tested positive. When semen specimens were included, all 3 specimens tested positive in only 19% of cases. Semen was the most sensitive single specimen, and, in 25.6% of cases, only semen specimens tested positive. Thus, prevalence of T. vaginalis infection in men is underestimated if only 1 specimen is tested.


Subject(s)
Semen/microbiology , Trichomonas Infections/diagnosis , Trichomonas vaginalis/isolation & purification , Urethra/microbiology , Adolescent , Adult , Animals , Antiprotozoal Agents/therapeutic use , HIV Infections/complications , Humans , Logistic Models , Longitudinal Studies , Malawi/epidemiology , Male , Metronidazole/therapeutic use , Middle Aged , Prevalence , Sensitivity and Specificity , Trichomonas Infections/drug therapy , Trichomonas Infections/epidemiology , Trichomonas Infections/urine , Urethritis/complications , Urethritis/drug therapy , Urethritis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...